参考文献/References:
[1] BARTHELS D, DAS H. Current advances in ischemic stroke research and therapies[J]. Biochimica et Biophysica Acta-Molecular Basis of Disease, 2020,1866(4): 165260.
[2] WU Simiao, WU Bo, LIU Ming, et al. Stroke in China:advances and challenges in epidemiology, prevention,and management[J]. Lancet Neurology, 2019, 18(4):394-405.
[3] BRAININ M. Stroke epidemiology in China: which are the next steps[J]. The Lancet Neurology, 2019, 18(4):325-326.
[4] FREITAS-ANDRADE M, BECHBERGER J F,MACVICAR B, et al. Pannexin1 knockout and blockade reduces ischemic stroke injury in female, but not in male mice[J]. Oncotarget, 2017, 8(23): 36973-36983.
[5] YEUNG A K, PATIL C S, JACKSON M F. Pannexin-1 in the CNS: emerging concepts in health and disease[J].Journal of Neurochemistry, 2020, 154(5): 468-485.
[6] LEMARI? J, GIBOT S. Soluble triggering receptor expressed on myeloid cells-1: diagnosis or prognosis[J].Critical Care Clinics, 2020, 36(1): 41-54.
[7] 戴道鹏, 沈迎, 张瑞岩, 等. 血清可溶性髓样细胞触发受体-1 水平对冠状动脉粥样斑块进展的预测价值[J]. 国际心血管病杂志, 2016, 43(5): 303-306. DAI Daopeng, SHEN Ying, ZHANG Ruiyan, et al.Value of serum soluble triggering receptor expressed on myeloid cells-1 level for predicting coronary plaque progression [J]. International Journal of Cardiovascular Disease,2016,43(5):303-306.
[8] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682. Chinese Society of Neurology, Chinese Stroke Society,Chinese Medical Associations. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018[J]. Chinese Journal of Neurology,2018,51(9):666-682.
[9] WANG Wenzhi, JIANG Bin, SUN Haixin, et al.Prevalence, incidence, and mortality of stroke in China:results from a nationwide Population-Based survey of 480 687 adults[J]. Circulation, 2017, 135(8): 759-771.
[10] 赵曼, 赵雅, 王禺, 等. 血清HCY, Cys C 和NTproBNP检测在急性脑梗死诊断及预后中的应用研究[J]. 现代检验医学杂志, 2019, 34(3): 70-73. ZHAO Man,ZHAO Ya,WANG Yu,et al. Clinical application of serum HCY,Cys C and NT-proBNP joint detection in diagnosis and prognosis of acute cerebral infarction [J]. Journal of Modern Laboratory Medicine,2019,34(3):70-73.
[11] KAMTCHUM-TATUENE J, JICKLING G C. Blood biomarkers for stroke diagnosis and management[J].Neuromolecular Medicine, 2019, 21(4): 344-368.
[12] SHAN Yisi, NI Yaohui, GAO Zhiwei. Pannexin-1 channel regulates ATP release in epilepsy[J].Neurochemical Research, 2020, 45(5): 965-971.
[13] GOOD M E, EUCKER S A, LI Jun, et al. Endothelial cell Pannexin1 modulates severity of ischemic stroke by regulating cerebral inflammation and myogenic tone[J]. JCI Insight, 2018, 3(6): 96272.
[14] WEI Ruili, BAO Wangxiao, HE Fangping, et al.Pannexin1 channel inhibitor (10panx) protects against transient focal cerebral ischemic injury by inhibiting RIP3 expression and inflammatory response in rats[J].Neuroscience, 2020, 437: 23-33.
[15] 刘小曼, 臧福才, 郎明非, 等.Pannexin-1 在急性缺血性脑卒中中的研究进展[J]. 卒中与神经疾病,2020, 27(4): 542-545. LIU Xiaoman, ZANG Fucai, LANG Mingfei,et al . Research progress of pannex in -1 in acute ischemic stroke[J]. Stroke and Nervous Diseases,2020,27(4):542-545.
[16] 刘美霞, 周龙. 缺血性脑卒中患者血清Pannexin1水平及其临床意义[J]. 中国现代医学杂志, 2020,30(8): 110-113. LIU Meixia, ZHOU Long. Serum Pannexin1 level in patients with ischemic stroke and its clinical significance [J]. China Journal of Modern Medicine,2020,30(8):110-113.
[17] PATOULIAS D, KALOGIROU M S, PATOULIAS I. Triggering receptor expressed on myeloid cells-1(TREM-1) and its soluble in the plasma form(sTREM-1) as a diagnostic biomarker in neonatal sepsis[J]. Folia Medica Cracoviensia, 2018, 58(2): 15-19.
[18] LIANG Yubin, SONG Pingping, ZHU Yunhui, et al.TREM-1-targeting LP17 attenuates cerebral ischemiainduced neuronal injury by inhibiting oxidative stress and pyroptosis[J]. Biochemical and Biophysical Research Communications, 2020, 529(3): 554-561.
[19] XU Pengfei, ZHANG Xiaohan, LIU Qian, et al. Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke[J]. Cell Death & Disease, 2019, 10(8): 555.
[20] GUERRERO W R, GOLUBCZYK D, WALCZAK P. Thrombus imaging in acute stroke[J]. Stroke, 2019,50(8): 1948-1949.
[21] WANG H M, GAO J H, LU J L. Pravastatin improves atherosclerosis in mice with hyperlipidemia by inhibiting TREM-1/DAP12[J]. European Review for Medical and Pharmacological Sciences, 2018, 22(15):4995-5003.
[22] SOLANKI A, BHATT L K, Johnston TP. Evolving targets for the treatment of atherosclerosis[J].Pharmacol Ther,2018 ,187:1-12.
相似文献/References:
[1]何凤娥,刘依霜,段春艳.ACI患者TEG各项参数与PAgT和D-二聚体之间的相关性[J].现代检验医学杂志,2017,32(01):134.[doi:10.3969/j.issn.1671-7414.2017.01.037]
HE Feng-e,LIU Yi-shuang,DUAN Chun-yan.Correlation between TEG Parameters and PAgT
and D-Dimer in Patients with ACIH[J].Journal of Modern Laboratory Medicine,2017,32(04):134.[doi:10.3969/j.issn.1671-7414.2017.01.037]
[2]王 禺,李秀娥,赵 曼,等.急性脑梗死患者的NT-proBNP和Hcy及部分凝血纤溶指标变化的临床意义[J].现代检验医学杂志,2017,32(03):89.[doi:10.3969/j.issn.1671-7414.2017.03.024]
WANG Yu,LI Xiu-e,ZHAO Man,et al.Clinical Significance of Changes in NT-proBNP,Hcy and Partial
Coagulation-Fibrinolytic Indexes with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2017,32(04):89.[doi:10.3969/j.issn.1671-7414.2017.03.024]
[3]刘学芳,霍 豆,赵 茜,等.急性脑梗死患者血清VEGF,SAA和Lp-PLA2联合检测的临床研究[J].现代检验医学杂志,2018,33(04):76.[doi:10.3969/j.issn.1671-7414.2018.04.020]
LIU Xue-fang,HUO-Dou,ZHAO-Qian,et al.Diagnostic Value of Combined Detection of VEGF,SAA
and Lp-PLA2 for Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2018,33(04):76.[doi:10.3969/j.issn.1671-7414.2018.04.020]
[4]张同庆,杨文东.急性脑梗死并发幽门螺旋杆菌感染者血脂水平及氧化应激反应的观察[J].现代检验医学杂志,2018,33(02):66.[doi:10.3969/j.issn.1671-7414.2018.02.001]
ZHANG Tong-qing,YANG Wen-dong.Observation of Serum Lipid Level and
Oxidative Stress Response in Patients with Acute Cerebral
Infarction Complicated with Helicobacter Pylori Infection[J].Journal of Modern Laboratory Medicine,2018,33(04):66.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[5]刘 莉,张 军.急性脑梗死患者血清hs-CRP,TNF-α和TIMP-1水平检测在疾病预后评估中的应用价值[J].现代检验医学杂志,2018,33(05):87.[doi:10.3969/j.issn.1671-7414.2018.05.023]
LIU Li,ZHANG Jun.Value of Serum hs-CRP,TNF-α and TIMP-1 Levels in Prognostic Evaluation of Patients with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2018,33(04):87.[doi:10.3969/j.issn.1671-7414.2018.05.023]
[6]陈 霏,王 碧.血清PDGF 及SDF-1 水平与急性脑梗死患者脑侧支循环建立的相关性研究[J].现代检验医学杂志,2020,35(01):82.[doi:10.3969/j.issn.1671-7414.2020.01.022]
CHEN Fei,WANG Bi.Study on the Correlation between Levels of MMP-9 and SDF-1 in Serumand the Establishment of Cerebral Collateral Circulation inPatients with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2020,35(04):82.[doi:10.3969/j.issn.1671-7414.2020.01.022]
[7]杨 华a,李致文b,曹明善a,等.急性脑梗死患者血清miR-130a 水平表达与溶栓后再出血转化风险的预测模型及验证[J].现代检验医学杂志,2022,37(06):28.[doi:10.3969/j.issn.1671-7414.2022.06.006]
YANG Huaa,LI Zhi-wenb,CAO Ming-shana,et al.Prediction Model and Validation of Serum miR-130a Expression in Patients with Acute Cerebral Infarction and the Risk of Hemorrhagic Transformation after Thrombolysis[J].Journal of Modern Laboratory Medicine,2022,37(04):28.[doi:10.3969/j.issn.1671-7414.2022.06.006]
[8]聂晓慧,薛 茜,寇文辉,等.急性脑梗死患者外周血LncRNA-NEAT1,miR-93-5p 表达水平及临床意义[J].现代检验医学杂志,2022,37(06):94.[doi:10.3969/j.issn.1671-7414.2022.06.017]
NIE Xiao-hui,XUE Qian,KOU Wen-hui,et al.Expression Level and Clinical Significance of Peripheral Blood LncRNANEAT1 and miR-93-5p in Patients with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2022,37(04):94.[doi:10.3969/j.issn.1671-7414.2022.06.017]
[9]张 磊,赵腾跃,李 彬.急性脑梗死患者血清Beclin-1,3-MST,TSP-1 表达水平及与病情和预后的相关性研究[J].现代检验医学杂志,2022,37(06):124.[doi:10.3969/j.issn.1671-7414.2022.06.023]
ZHANG Lei,ZHAO Teng-yue,LI Bin.Serum Beclin-1, 3-MST and TSP-1 Expression Levels in Patients with Acute Cerebral Infarction and Their Correlation with Disease Condition and Prognosis[J].Journal of Modern Laboratory Medicine,2022,37(04):124.[doi:10.3969/j.issn.1671-7414.2022.06.023]
[10]牛立远a,刘会雪a,史立彬b.急性脑梗死患者血清CCR5 和miR-211-5p 表达水平及其临床意义[J].现代检验医学杂志,2023,38(01):128.[doi:10.3969/j.issn.1671-7414.2023.01.024]
NIU Li-yuana,LIU Hui-xuea,SHI Li-binb.Expression Levels and Their Clinical Significance of Serum CCR5 and miR-211-5p in Patients with Acute Cerebral Infarction[J].Journal of Modern Laboratory Medicine,2023,38(04):128.[doi:10.3969/j.issn.1671-7414.2023.01.024]